► Oncology  ► Disease progression and treatment optimization   ► EGFR Mutation Analysis

EGFR Mutation Analysis 

Test
   EGFR Mutation Analysis 
Related to
   Lung cancer
Target population
   Lung cancer patients who have been diagnosed with NSCLC
Objective
   To assess the patient’s potential benefit from anti-EFGR therapy (Gefitinib/Erlotinib)
Sample type
   Formalin-fixed paraffin-embedded (FFPE) tissue taken from surgery / biopsy
Procedure
   Genetic analysis of tumor cells
Availability
   Available